and Danish pharmaceutical company Novo Nordisk to localize the manufacturing of advanced GLP-1 treatments for diabetes and obesity. This agreement is part of the Ministry of Investment's efforts to ...

As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.

Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was ...

When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge ...

Our premium News+ ad-free experience – only $10 more every 4 weeks!

A partial phase out of a top insulin product by Danish drug maker Novo Nordisk may open a bounty for Eris Pharma and its manufacturing partner Biocon Biologics. “It is a small emergency,” says Amit ...

MILWAUKEE -- Right-hander Quinn Priester had initially been the Brewers’ probable ... It wasn’t about gamesmanship, as the team informed Chicago well in advance about the change. Manager Pat Murphy ...

The jury, as it should be, is still out on the trade that brought Quinn Priester to Milwaukee. But early deliberations have begun, and they aren’t trending in a positive way for the Milwaukee ...

Some Nordic firms such as Volvo Group, Novo Nordisk, Nokia, KONE, and IKEA have already set up GCCs in India due to its deep expertise in IT, artificial intelligence (AI), analytics, and engineering.

Novo Nordisk said the Food and Drug Administration ... Last month, Eli Lilly said its oral obesity and type 2 diabetes treatment, called orforglipron, met its goals in the first of several studies ...

which is FDA-approved for diabetes. One stock that probably won't stay cheap With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered ...